Laraway Financial Advisors’s CVS Health CVS Stock Holding History

Laraway Financial Advisors’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$254K	Sell	2,456 -100	-4%	-$8.93K	0.15%	120
2026 Q1	$184K	Sell	2,556 -700	-21%	-$53.9K	0.13%	127
2025 Q4	$258K	Sell	3,256 -125	-4%	-$9.85K	0.17%	120
2025 Q3	$255K	Buy	3,381 +296	+10%	+$20.3K	0.17%	116
2025 Q2	$213K	Hold	3,085	–	–	0.16%	117
2025 Q1	$209K	Hold	3,085	–	–	0.17%	115
2024 Q4	$138K	Sell	3,085 -250	-7%	-$14K	0.11%	118
2024 Q3	$210K	Buy	3,335 +660	+25%	+$38.5K	0.17%	111
2024 Q2	$158K	Buy	2,675 +50	+2%	+$3.13K	0.14%	111
2024 Q1	$209K	Hold	2,625	–	–	0.18%	106
2023 Q4	$207K	Buy	2,625 +285	+12%	+$20.3K	0.2%	104
2023 Q3	$163K	Hold	2,340	–	–	0.17%	105
2023 Q2	$162K	Sell	2,340 -200	-8%	-$14.2K	0.16%	105
2023 Q1	$189K	Hold	2,540	–	–	0.19%	105
2022 Q4	$237K	Buy	2,540 +10	+0.4%	+$965	0.25%	100
2022 Q3	$241K	Buy	2,530 +150	+6%	+$14.8K	0.27%	95
2022 Q2	$220K	Sell	2,380 -150	-6%	-$14.6K	0.23%	99
2022 Q1	$256K	Hold	2,530	–	–	0.23%	100
2021 Q4	$260K	Buy	+2,530	New	+$234K	0.23%	94

Other funds holding CVS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Laraway Financial Advisors's CVS Position: Q2 2026 in Review

Laraway Financial Advisors reduced its CVS Health (CVS) stake by 3.9% in Q2 2026, selling an estimated $8.93K and leaving 2,456 shares worth $254K. The position accounts for 0.15% of the portfolio, ranked #120.

Laraway Financial Advisors first reported a position in CVS in Q4 2021 and has held it in 19 quarters since. The position peaked at $260K in Q4 2021. 2,068 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

Laraway Financial Advisors held 2,456 shares of CVS Health worth $254K as of Q2 2026.
Laraway Financial Advisors sold 100 CVS Health shares in Q2 2026, an estimated $8.93K.
CVS Health made up 0.15% of Laraway Financial Advisors's portfolio in Q2 2026, its #120 holding.
Laraway Financial Advisors first reported a position in CVS Health in Q4 2021 and has held it in 19 quarters since.
Laraway Financial Advisors's CVS Health position peaked at $260K in Q4 2021.
2,068 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Laraway Financial Advisors's 13F filing for Q2 2026, filed 3 Aug 2026.